Literature DB >> 17245754

Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics.

Hasan Siddiqui1, Sejal R Fox, Ranjaka W Gunawardena, Erik S Knudsen.   

Abstract

Heterochromatin domains are important for gene silencing, centromere organization, and genomic stability. These genomic domains are marked with specific histone modifications, heterochromatin protein 1 (HP1) binding and DNA methylation. The retinoblastoma tumor suppressor, RB mediates transcriptional repression and functionally interacts with a number of factors that are involved in heterochromatin biology including HP1, Suv39h1, DNMT1, and components of the SWI/SNF chromatin remodeling complex. To analyze the specific influence of RB loss on chromatin modification, mouse adult fibroblasts (MAFs) derived from Rb(loxP/loxP) mice were utilized to acutely knockout RB. In this setting, target genes of RB are deregulated. Additionally, changes in histone modifications were observed. Specifically, histone H4 lysine 20 trimethylation was absent from heterochromatin domains following loss of RB and there were changes in the relative levels of histone modifications between RB-proficient and deficient cells. While RB loss significantly altered the modifications associated with heterochromatin domains, these domains were readily identified and efficiently mediated the recruitment of HP1alpha. Kinetic analyses of HP1alpha within the heterochromatin domains present in RB-deficient cells indicated that loss of RB retarded HP1alpha dynamics, indicating that HP1alpha is paradoxically more tightly associated with heterochromatin in the absence of RB function. Combined, these analyses demonstrate that loss of RB has global effects on chromatin modifications and dynamics. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245754     DOI: 10.1002/jcp.20913

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

Review 1.  Epigenetic regulation of human retinoblastoma.

Authors:  Usha Singh; Manzoor Ahmad Malik; Sandeep Goswami; Swati Shukla; Jasbir Kaur
Journal:  Tumour Biol       Date:  2016-09-17

Review 2.  Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy.

Authors:  Erik S Knudsen; Steven C Pruitt; Pamela A Hershberger; Agnieszka K Witkiewicz; David W Goodrich
Journal:  Trends Cancer       Date:  2019-04-30

3.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

4.  Genomic size of CENP-A domain is proportional to total alpha satellite array size at human centromeres and expands in cancer cells.

Authors:  Lori L Sullivan; Christopher D Boivin; Brankica Mravinac; Ihn Young Song; Beth A Sullivan
Journal:  Chromosome Res       Date:  2011-04-12       Impact factor: 5.239

5.  Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion.

Authors:  Amity L Manning; Stephanie A Yazinski; Brandon Nicolay; Alysia Bryll; Lee Zou; Nicholas J Dyson
Journal:  Mol Cell       Date:  2014-03-06       Impact factor: 17.970

Review 6.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

Review 7.  Regulation of transcription and chromatin structure by pRB: here, there and everywhere.

Authors:  Srikanth Talluri; Frederick A Dick
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 8.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

Review 9.  pRb, a local chromatin organizer with global possibilities.

Authors:  Michelle S Longworth; Nicholas J Dyson
Journal:  Chromosoma       Date:  2009-08-28       Impact factor: 4.316

10.  Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model.

Authors:  A Kathleen McClendon; Jeffry L Dean; Adam Ertel; Erik S Knudsen
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.